Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 792

1.

The impact of attention deficit hyperactivity disorder in obsessive-compulsive disorder subjects.

Blanco-Vieira T, Santos M, Ferrão YA, Torres AR, Miguel EC, Bloch MH, Leckman JF, do Rosario MC.

Depress Anxiety. 2019 Apr 16. doi: 10.1002/da.22898. [Epub ahead of print]

PMID:
30990937
2.

The Potential of Cannabinoid-Based Treatments in Tourette Syndrome.

Artukoglu BB, Bloch MH.

CNS Drugs. 2019 Apr 11. doi: 10.1007/s40263-019-00627-1. [Epub ahead of print]

PMID:
30977108
3.

Severe Illness Anxiety Treated by Integrating Inpatient Psychotherapy With Medical Care and Minimizing Reassurance.

Higgins-Chen AT, Abdallah SB, Dwyer JB, Kaye AP, Angarita GA, Bloch MH.

Front Psychiatry. 2019 Mar 22;10:150. doi: 10.3389/fpsyt.2019.00150. eCollection 2019.

4.

Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.

Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Lobo MD, Sharp ASP, Bloch MJ, Basile J, Wang Y, Saxena M, Lurz P, Rader F, Sayer J, Fisher NDL, Fouassier D, Barman NC, Reeve-Stoffer H, McClure C, Kirtane AJ; RADIANCE-HTN Investigators.

Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040451. [Epub ahead of print]

PMID:
30880441
5.

Mechanism of glucocerebrosidase activation and dysfunction in Gaucher disease unraveled by molecular dynamics and deep learning.

Romero R, Ramanathan A, Yuen T, Bhowmik D, Mathew M, Munshi LB, Javaid S, Bloch M, Lizneva D, Rahimova A, Khan A, Taneja C, Kim SM, Sun L, New MI, Haider S, Zaidi M.

Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):5086-5095. doi: 10.1073/pnas.1818411116. Epub 2019 Feb 26.

PMID:
30808805
6.

Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis.

Dobson ET, Bloch MH, Strawn JR.

J Clin Psychiatry. 2019 Jan 29;80(1). pii: 17r12064. doi: 10.4088/JCP.17r12064.

7.

Interrater reliability of the standardized Timed Up and Go Test when used in hospitalized and community-dwelling older individuals.

Kristensen MT, Bloch ML, Jønsson LR, Jakobsen TL.

Physiother Res Int. 2019 Apr;24(2):e1769. doi: 10.1002/pri.1769. Epub 2019 Jan 18.

PMID:
30657232
8.

Policy Change for Deep Vein Thrombosis: Effects on Length of Stay and Hospitalization Costs of Moving From Warfarin to Direct Oral Anticoagulants.

Porath AD, Clodfelter S, Slaton T, Bookhart BK, Kozma CM, Rand ML, Bloch MJ.

Clin Ther. 2019 Feb;41(2):269-279. doi: 10.1016/j.clinthera.2018.12.006. Epub 2019 Jan 11.

PMID:
30642614
9.

History and Justification of a National Blood Pressure Measurement Validated Device Listing.

Cohen JB, Padwal RS, Gutkin M, Green BB, Bloch MJ, Germino FW, Sica DA, Viera AJ, Bluml BM, White WB, Taler SJ, Yarows S, Shimbo D, Townsend RR.

Hypertension. 2019 Feb;73(2):258-264. doi: 10.1161/HYPERTENSIONAHA.118.11990. No abstract available.

PMID:
30580681
10.

Predictors of Daily Adherence to HIV Pre-exposure Prophylaxis in Gay/Bisexual Men in the PRELUDE Demonstration Project.

Vaccher SJ, Marzinke MA, Templeton DJ, Haire BG, Ryder N, McNulty A, Foster R, Grulich AE, Zablotska IB; PRELUDE Study Team; NSW HIV Prevention Partnership Project.

AIDS Behav. 2018 Dec 6. doi: 10.1007/s10461-018-2353-5. [Epub ahead of print]

PMID:
30523489
11.

Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.

Jakubovski E, Johnson JA, Nasir M, Müller-Vahl K, Bloch MH.

Depress Anxiety. 2019 Mar;36(3):198-212. doi: 10.1002/da.22854. Epub 2018 Nov 26. Review.

PMID:
30479005
12.

Cardiovascular disease and diabetes in HIV-positive and HIV-negative gay and bisexual men over the age of 55 years in Australia: insights from the Australian Positive & Peers Longevity Evaluation Study.

Puhr R, Petoumenos K, Huang R, Templeton DJ, Woolley I, Bloch M, Russell D, Law MG, Cooper DA.

HIV Med. 2019 Feb;20(2):121-130. doi: 10.1111/hiv.12689. Epub 2018 Nov 26.

PMID:
30474916
13.

Frailty in people living with HIV.

Bloch M.

AIDS Res Ther. 2018 Nov 16;15(1):19. doi: 10.1186/s12981-018-0210-2. Review.

14.

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.

Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man C, Currie A, Underwood M, Tenorio AR, Pappa K, Wynne B, Fettiplace A, Gartland M, Aboud M, Smith K; GEMINI Study Team.

Lancet. 2019 Jan 12;393(10167):143-155. doi: 10.1016/S0140-6736(18)32462-0. Epub 2018 Nov 9. Erratum in: Lancet. 2018 Nov 28;:.

PMID:
30420123
15.

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.

Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Ruff CT, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde AM, Sabatine MS; DECLARE–TIMI 58 Investigators.

N Engl J Med. 2019 Jan 24;380(4):347-357. doi: 10.1056/NEJMoa1812389. Epub 2018 Nov 10.

PMID:
30415602
16.

Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.

Grulich AE, Guy R, Amin J, Jin F, Selvey C, Holden J, Schmidt HA, Zablotska I, Price K, Whittaker B, Chant K, Cooper C, McGill S, Telfer B, Yeung B, Levitt G, Ogilvie EE, Dharan NJ, Hammoud MA, Vaccher S, Watchirs-Smith L, McNulty A, Smith DJ, Allen DM, Baker D, Bloch M, Bopage RI, Brown K, Carr A, Carmody CJ, Collins KL, Finlayson R, Foster R, Jackson EY, Lewis DA, Lusk J, O'Connor CC, Ryder N, Vlahakis E, Read P, Cooper DA; Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) research group.

Lancet HIV. 2018 Nov;5(11):e629-e637. doi: 10.1016/S2352-3018(18)30215-7. Epub 2018 Oct 17.

PMID:
30343026
17.

Identifying standardized definitions of treatment response in trichotillomania: A meta-analysis.

Farhat LC, Olfson E, Li F, Telang S, Bloch MH.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:446-455. doi: 10.1016/j.pnpbp.2018.10.009. Epub 2018 Oct 16.

PMID:
30336171
18.

High Adherence to HIV Pre-exposure Prophylaxis and No HIV Seroconversions Despite High Levels of Risk Behaviour and STIs: The Australian Demonstration Study PrELUDE.

Zablotska IB, Vaccher SJ, Bloch M, Carr A, Foster R, Grulich AE, Guy R, McNulty A, Ooi C, Pell C, Poynten IM, Prestage G, Ryder N, Templeton D; PrELUDE Study Group.

AIDS Behav. 2018 Oct 4. doi: 10.1007/s10461-018-2290-3. [Epub ahead of print]

PMID:
30284653
19.

Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study.

Domany Y, Bleich-Cohen M, Tarrasch R, Meidan R, Litvak-Lazar O, Stoppleman N, Schreiber S, Bloch M, Hendler T, Sharon H.

Br J Psychiatry. 2019 Jan;214(1):20-26. doi: 10.1192/bjp.2018.196. Epub 2018 Sep 24.

PMID:
30246667
20.

Prophylactic SSRI treatment for women suffering from mood and anxiety symptoms undergoing in vitro fertilization-a prospective placebo-controlled study.

Aisenberg Romano G, Fried Zaig I, Halevy A, Azem F, Amit A, Bloch M.

Arch Womens Ment Health. 2018 Sep 17. doi: 10.1007/s00737-018-0911-5. [Epub ahead of print]

PMID:
30225529

Supplemental Content

Loading ...
Support Center